ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

Delayed Data
As of Mar 16
 +0.0005 / +0.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +1,804.76% increase from the last price of 0.21.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.67%
Growthannually 11.43%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.